Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
Johns Hopkins University · Johns Hopkins Medicine · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
703
total citations
- FWCI
- 47.92
- Percentile
- 100%
- References
- 18
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Medicine
- Ranibizumab
- Central retinal vein occlusion
- Macular edema
- Ophthalmology
- Visual acuity
- Randomized controlled trial
- Confidence interval
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.